Cargando…

What next after GDP-based cost-effectiveness thresholds?

Public payers around the world are increasingly using cost-effectiveness thresholds (CETs) to assess the value-for-money of an intervention and make coverage decisions. However, there is still much confusion about the meaning and uses of the CET, how it should be calculated, and what constitutes an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Y-Ling, Blecher, Mark, Chalkidou, Kalipso, Culyer, Anthony, Claxton, Karl, Edoka, Ijeoma, Glassman, Amanda, Kreif, Noemi, Jones, Iain, Mirelman, Andrew J., Nadjib, Mardiati, Morton, Alec, Norheim, Ole Frithjof, Ochalek, Jessica, Prinja, Shankar, Ruiz, Francis, Teerawattananon, Yot, Vassall, Anna, Winch, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Open Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851575/ https://www.ncbi.nlm.nih.gov/pubmed/33575544 http://dx.doi.org/10.12688/gatesopenres.13201.1

Ejemplares similares

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018)

Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

How can we make better health decisions: a Best Buy for all?: Commentary based on discussions at iDSI roundtable on 2 (nd) May 2019 London, UK
por: O'Brien, Niki, et al.
Publicado: (2020)

Charging for the use of survey instruments on population health: the case of quality-adjusted life years
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Value-based tiered pricing for universal health coverage: an idea worth revisiting
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

What is the value of explicit priority setting for health interventions? A simulation study
por: Barlow, Euan, et al.
Publicado: (2022)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
por: Teerawattananon, Yot, et al.
Publicado: (2021)

We need a NICE for global development spending
por: Chalkidou, Kalipso, et al.
Publicado: (2017)

Priority-setting for achieving universal health coverage
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE
por: Tantivess, Sripen, et al.
Publicado: (2017)

Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact
por: Millar, Robyn, et al.
Publicado: (2021)

How Should Global Fund Use Value-for-Money Information to Sustain its Investments in Graduating Countries?
por: Kanpirom, Kitti, et al.
Publicado: (2017)

Distributional Cost-Effectiveness Analysis Comes of Age
por: Cookson, Richard, et al.
Publicado: (2021)

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
por: Culyer, Anthony J., et al.
Publicado: (2019)

Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK
por: Culyer, Anthony J., et al.
Publicado: (2021)

Methodological Variation in Economic Evaluations Conducted in Low- and Middle-Income Countries: Information for Reference Case Development
por: Santatiwongchai, Benjarin, et al.
Publicado: (2015)

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations
por: Turner, Hugo C., et al.
Publicado: (2021)

Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia
por: Afiatin,, et al.
Publicado: (2017)

Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries
por: Vassall, Anna, et al.
Publicado: (2022)

Using Cost-Effectiveness Analysis to Address Health Equity Concerns
por: Cookson, Richard, et al.
Publicado: (2017)

Evidence-informed capacity building for setting health priorities in low- and middle-income countries: A framework and recommendations for further research
por: Li, Ryan, et al.
Publicado: (2017)

Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa
por: MacQuilkan, Kim, et al.
Publicado: (2018)

Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India
por: Dabak, Saudamini Vishwanath, et al.
Publicado: (2018)

Adherence to the iDSI reference case among published cost-per-DALY averted studies
por: Emerson, Joanna, et al.
Publicado: (2019)

Lockdown is not egalitarian: the costs fall on the global poor
por: Broadbent, Alexander, et al.
Publicado: (2020)

The use of cost-effectiveness analysis for health benefit package design – should countries follow a sectoral, incremental or hybrid approach?
por: Baltussen, Rob, et al.
Publicado: (2023)

Historical development of the htasialink network and its key determinants of success
por: Teerawattananon, Yot, et al.
Publicado: (2018)

Recalibrating the notion of modelling for policymaking during pandemics
por: Teerawattananon, Yot, et al.
Publicado: (2022)

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund
por: Teerawattananon, Yot, et al.
Publicado: (2013)

How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations
por: Hauck, K., et al.
Publicado: (2019)

Prevention of non-communicable disease: best buys, wasted buys, and contestable buys
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2020)

Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates
por: Edney, Laura C., et al.
Publicado: (2021)

Fairer financing of vaccines in a world living with COVID-19
por: Megiddo, Itamar, et al.
Publicado: (2020)

Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India
por: Chugh, Yashika, et al.
Publicado: (2021)

Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips
por: Zhu, Alec, et al.
Publicado: (2022)

Sharing the British National Health Service around the world: a self-interested perspective
por: Chalkidou, Kalipso, et al.
Publicado: (2013)

Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience()
por: Downey, L.E., et al.
Publicado: (2020)

Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data
por: Ochalek, Jessica, et al.
Publicado: (2018)

Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries
por: Lomas, James, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jk27g9cr0hg450r73ju9n90f9p